Tag Archives: Favipiravir

Significant expansion of production facilities for biopharmaceuticals in Denmark Accelerate expansion of outsourced biopharmaceutical development and manufacturing business with large investment of 100 billion yen Doubled the production capacity of the drug substance, and established a contracted system that allows one-site, one-stop support from the drug substance to formulation and packaging FUJIFILM Corporation (President: Kenji Sukeno ) […]

Tonix Pharmaceuticals Announces FUJIFILM Diosynth Biotechnologies to be Manufacturing Partner for COVID-19 Vaccine Candidate TNX-1800 Collaboration includes Development of Manufacturing Processes and to Supply Clinical Trial Material to Support Tonix’s Development of TNX-1800 NEW YORK, June 01, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, […]

Fujifilm to Develop AI-based Technology to Aid COVID-19-Induced Pneumonia Diagnosis and Assess The Effectiveness of Treatments Company commences joint research study with leading medical institutions in Japan, applying lesion quantification technology for pneumonia TOKYO, May 19, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) is commencing a research study to develop Artificial Intelligence (AI)-based technology to […]

We have been following Fujifilm Avigan (Favipiravir) and COVID-19 involvement for a while ( 1, 2, 3, 4, 5, 6, 7, 8, 9, 10. 11, 12, 13) and trials keep coming up with positive results. It is now being reported that Fujifilm is sharing their “wonder drug” via the Japanese Government with 43 countries for approval in the treatments of COVID-19 via the United Nations Office for […]

Translated Notification of application of public medical insurance to the new gene detection kit “SARS-CoV-2 RT-qPCR Detection kit” for coronavirus that greatly shortens PCR test time (Fujifilm Wako Pure Chemical) FUJIFILM Wako Pure Chemical Industries, Ltd. (Head office: Chuo-ku, Osaka, President: Kazuo Shiraki) has announced that the research reagent “SARS-CoV-2 RT-qPCR Detection kit” released on April 15 […]

FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies HILLERØD, Denmark, April 30, 2020 – FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 […]